Key facts
- Evidence’s last known valuation is $2.5M (Jan 2025).
- It has raised $680K; the latest was Early Stage VC ($420K) in Jan 2025.
- Notable investors include DRIVE ( KI Innovations Business Incubator), Sciety.
- Evidence has filed 1 Form D with the SEC, most recently Sep 2021 ($75K sold to 1 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Evidence
- ·The full record, as it builds
Funding rounds
No funding rounds for Evidence are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evidence
Operator of a healthcare software platform intended to enhance healthcare operations through effective demand and capacity planning. The company specializes in production planning, healthcare operations, simulation and benchmarking capabilities, optimizing resource use, and improving care quality by consolidating all critical functions into a single system, enabling clients to balance quality with cost and improve sustainability across healthcare practices.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2022
- Employees
- 10
- Website
- evidenceoperations.com/
- Ownership
- Privately Held (backing)
Evidence doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evidence shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evidence in its N-PORT filings yet. We sweep new filings monthly.